Jointown Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency
Jointown Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jointown Pharmaceutical Group Co Ltd (600998) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥528.22 Million ≈ $77.30 Million USD) by net assets (CN¥35.07 Billion ≈ $5.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Jointown Pharmaceutical Group Co Ltd (2007–2024)
Cash flow conversion efficiency of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. This chart illustrates how Jointown Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Jointown Pharmaceutical Group Co Ltd stock price today for real-time trading data and today's change.
Jointown Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained
Jointown Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Jointown Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jointown Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 600998 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wuchan Zhongda Group Co Ltd
SHG:600704
|
-0.088x |
|
Karur Vysya Bank Limited
NSE:KARURVYSYA
|
-0.552x |
|
Centre Testing Intl Shenzhen
SHE:300012
|
0.052x |
|
Bread Financial Holdings, Inc.
NYSE:BFH
|
0.158x |
|
Sonae SGPS SA
LS:SON
|
0.018x |
|
BancFirst Corporation
NASDAQ:BANF
|
0.012x |
|
GPGI, Inc.
NYSE:GPGI
|
-0.017x |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521
|
0.028x |
Annual Cash Flow Conversion Efficiency for Jointown Pharmaceutical Group Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Jointown Pharmaceutical Group Co Ltd from 2007 to 2024. Review 600998 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥33.59 Billion ≈ $4.92 Billion |
CN¥3.08 Billion ≈ $451.07 Million |
0.092x | -43.44% |
| 2023-12-31 | CN¥29.48 Billion ≈ $4.31 Billion |
CN¥4.78 Billion ≈ $699.79 Million |
0.162x | +16.75% |
| 2022-12-31 | CN¥28.69 Billion ≈ $4.20 Billion |
CN¥3.99 Billion ≈ $583.31 Million |
0.139x | +8.76% |
| 2021-12-31 | CN¥27.07 Billion ≈ $3.96 Billion |
CN¥3.46 Billion ≈ $506.17 Million |
0.128x | -4.96% |
| 2020-12-31 | CN¥25.62 Billion ≈ $3.75 Billion |
CN¥3.44 Billion ≈ $503.95 Million |
0.134x | +6.70% |
| 2019-12-31 | CN¥21.97 Billion ≈ $3.21 Billion |
CN¥2.77 Billion ≈ $405.03 Million |
0.126x | +110.15% |
| 2018-12-31 | CN¥20.38 Billion ≈ $2.98 Billion |
CN¥1.22 Billion ≈ $178.82 Million |
0.060x | +215.75% |
| 2017-12-31 | CN¥19.54 Billion ≈ $2.86 Billion |
CN¥-1.01 Billion ≈ $-148.09 Million |
-0.052x | -244.26% |
| 2016-12-31 | CN¥12.01 Billion ≈ $1.76 Billion |
CN¥431.26 Million ≈ $63.11 Million |
0.036x | -18.91% |
| 2015-12-31 | CN¥9.85 Billion ≈ $1.44 Billion |
CN¥435.96 Million ≈ $63.79 Million |
0.044x | +308.58% |
| 2014-12-31 | CN¥8.09 Billion ≈ $1.18 Billion |
CN¥-171.68 Million ≈ $-25.12 Million |
-0.021x | -181.86% |
| 2013-12-31 | CN¥5.34 Billion ≈ $781.30 Million |
CN¥138.47 Million ≈ $20.26 Million |
0.026x | +133.99% |
| 2012-12-31 | CN¥4.84 Billion ≈ $707.64 Million |
CN¥-368.93 Million ≈ $-53.99 Million |
-0.076x | +4.45% |
| 2011-12-31 | CN¥4.30 Billion ≈ $629.75 Million |
CN¥-343.61 Million ≈ $-50.28 Million |
-0.080x | +69.06% |
| 2010-12-31 | CN¥4.00 Billion ≈ $585.15 Million |
CN¥-1.03 Billion ≈ $-150.99 Million |
-0.258x | +17.27% |
| 2009-12-31 | CN¥1.67 Billion ≈ $244.77 Million |
CN¥-521.70 Million ≈ $-76.34 Million |
-0.312x | -193.12% |
| 2008-12-31 | CN¥1.48 Billion ≈ $216.16 Million |
CN¥494.75 Million ≈ $72.40 Million |
0.335x | +550.37% |
| 2007-12-31 | CN¥1.28 Billion ≈ $187.41 Million |
CN¥65.95 Million ≈ $9.65 Million |
0.051x | -- |
About Jointown Pharmaceutical Group Co Ltd
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added serv… Read more